We are live on ! Find out more
NXTC icon

NextCure
NXTC

43 hedge funds and large institutions have $24M invested in NextCure in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $19.6M → $24M (+$4.34M)

0.01% more ownership

Funds ownership: 3.98% → 3.99% (+0.01%)

0% more funds holding

Funds holding: 43 → 43 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

Holders
43
Holders Change
–
Holders Change %
0%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
10
Closed
5
Calls
$108K
Puts
–
Net Calls
+$108K
Net Calls Change
-$123K

Top Buyers

Rank Fund Capital Flow
1
AI
Acuitas Investments
Washington
+$471K
2
CPA
Cardiff Park Advisors
California
+$430K
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$72.1K
4
IC
IEQ Capital
California
+$61.3K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$18.2K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$194K
2
Citadel Advisors
Citadel Advisors
Florida
-$142K
3
Goldman Sachs
Goldman Sachs
New York
-$138K
4
Norges Bank
Norges Bank
Norway
-$76.8K
5
MAM
Marquette Asset Management
Minnesota
-$76.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$4.88M – – –
SI
2
Sofinnova Investments
California
$4.81M – – –
Millennium Management
3
Millennium Management
New York
$2.54M -$73.8K -3,747 -3%
BlackRock
4
BlackRock
New York
$1.67M +$1.48K +75 +0.1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.64M – – –
LFCM
6
Long Focus Capital Management
Puerto Rico
$1M – – –
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$878K – – –
TCM
8
Tang Capital Management
California
$720K – – –
Citadel Advisors
9
Citadel Advisors
Florida
$708K -$142K -7,215 -18%
Federated Hermes
10
Federated Hermes
Pennsylvania
$661K -$35.5K -1,802 -6%
BCM
11
BML Capital Management
Indiana
$552K – – –
AI
12
Acuitas Investments
Washington
$516K +$471K +23,903 New
CPA
13
Cardiff Park Advisors
California
$472K +$430K +21,833 New
Renaissance Technologies
14
Renaissance Technologies
New York
$445K +$4.43K +225 +1%
DCM
15
DAFNA Capital Management
California
$338K – – –
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$315K -$49.7K -2,524 -15%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$284K -$17.9K -910 -6%
Macquarie Group
18
Macquarie Group
Australia
$270K – – –
SCM
19
Sio Capital Management
New York
$234K – – –
BCM
20
Bridgeway Capital Management
Texas
$170K – – –
Two Sigma Advisers
21
Two Sigma Advisers
New York
$134K -$53.5K -2,717 -31%
Barclays
22
Barclays
United Kingdom
$122K – – –
State Street
23
State Street
Massachusetts
$103K – – –
Assenagon Asset Management
24
Assenagon Asset Management
Luxembourg
$79.1K +$72.1K +3,660 New
Northern Trust
25
Northern Trust
Illinois
$78.3K +$748 +38 +1%
1
2

NXTC Hedge Fund Activity: Q2 2023 in Review

43 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q2 2023, worth a combined $24M — up 22% from $19.6M a quarter earlier.

Fund positioning in NXTC was balanced in Q2 2023: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 10 trimmed.

The largest buyer was Acuitas Investments, opening a new position worth an estimated $471K. The largest seller was Morgan Stanley, cutting an estimated $194K.

  • 43 institutional investors held NextCure (NXTC) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $24M of NextCure stock for Q2 2023, up 22% quarter-over-quarter.
  • 5 funds opened new NextCure positions in Q2 2023 and 5 closed out, a net change of 0 holders.
  • The largest NextCure buyer in Q2 2023 was Acuitas Investments, an estimated $471K added.
  • The largest NextCure seller in Q2 2023 was Morgan Stanley, an estimated $194K sold.

Based on aggregated 13F filings for Q2 2023.